INRAYUS Trademark

Trademark Overview

On Friday, November 20, 2020, a trademark application was filed for INRAYUS with the United States Patent and Trademark Office. The USPTO has given the INRAYUS trademark a serial number of 90332861. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2024. This trademark is owned by Sunovion Pharmaceuticals Inc. The INRAYUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders

General Information

Serial Number90332861
Word MarkINRAYUS
Filing DateFriday, November 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceutical preparations for treating schizophrenia; pharmaceutical preparations for treating cognitive disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSunovion Pharmaceuticals Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752
Party NameSunovion Pharmaceuticals Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarlborough, MA 01752

Trademark Events

Event DateEvent Description
Tuesday, November 24, 2020NEW APPLICATION ENTERED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 4, 2021ASSIGNED TO EXAMINER
Monday, May 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 30, 2022SOU TEAS EXTENSION RECEIVED
Sunday, January 30, 2022SOU EXTENSION 1 FILED
Sunday, January 30, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 24, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 24, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022SOU EXTENSION 2 FILED
Tuesday, June 21, 2022SOU EXTENSION 2 GRANTED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 3 FILED
Tuesday, December 13, 2022SOU EXTENSION 3 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 23, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 23, 2023SOU EXTENSION 4 FILED
Friday, June 23, 2023SOU EXTENSION 4 GRANTED
Tuesday, June 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 5 FILED
Monday, January 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 29, 2024SOU EXTENSION 5 GRANTED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

inrayus pharmaceutical treating preparations disorders schizophrenia cognitive nervous central system diseases